Literature DB >> 16235329

Optimal timing for intravenous administration set replacement.

D Gillies1, L O'Riordan, M Wallen, A Morrison, K Rankin, S Nagy.   

Abstract

BACKGROUND: Administration of intravenous therapy is a common occurrence within the hospital setting. Routine replacement of administration sets has been advocated to reduce intravenous infusion contamination. If decreasing the frequency of changing intravenous administration sets does not increase infection rates, a change in practice could result in considerable cost savings.
OBJECTIVES: The objective of this review was to identify the optimal interval for the routine replacement of intravenous administration sets when infusate or parenteral nutrition (lipid and non-lipid) solutions are administered to people in hospital via central or peripheral venous catheters. SEARCH STRATEGY: We searched The Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, CINAHL, EMBASE: all from inception to February 2004; reference lists of identified trials, and bibliographies of published reviews. We also contacted researchers in the field. We did not have a language restriction. SELECTION CRITERIA: We included all randomized or quasi-randomized controlled trials addressing the frequency of replacing intravenous administration sets when parenteral nutrition (lipid and non-lipid containing solutions) or infusions (excluding blood) were administered to people in hospital via a central or peripheral catheter. DATA COLLECTION AND ANALYSIS: Two authors assessed all potentially relevant studies. We resolved disagreements between the two authors by discussion with a third author. We collected data for the outcomes; infusate contamination; infusate-related bloodstream infection; catheter contamination; catheter-related bloodstream infection; all-cause bloodstream infection and all-cause mortality. MAIN
RESULTS: We identified 23 references for review. We excluded eight of these studies; five because they did not fit the inclusion criteria and three because of inadequate data. We extracted data from the remaining 15 references (13 studies) with 4783 participants. We conclude that there is no evidence that changing intravenous administration sets more often than every 96 hours reduces the incidence of bloodstream infection. We do not know whether changing administration sets less often than every 96 hours affects the incidence of infection. In addition, we found that there were no differences between participants with central versus peripheral catheters; nor between participants who did and did not receive parenteral nutrition, or between children and adults. AUTHORS'
CONCLUSIONS: It appears that administration sets that do not contain lipids, blood or blood products may be left in place for intervals of up to 96 hours without increasing the incidence of infection. There was no evidence to suggest that administration sets which contain lipids should not be changed every 24 hours as currently recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235329     DOI: 10.1002/14651858.CD003588.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  10 in total

Review 1.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

Review 2.  Does decreasing the frequency of changing intravenous administration sets (>24 h) increase the incidence of sepsis in neonates receiving total parenteral nutrition?

Authors:  Nevart Chirinian; Vibhuti Shah
Journal:  Paediatr Child Health       Date:  2012-11       Impact factor: 2.253

3.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

4.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

Review 5.  Focus on peripherally inserted central catheters in critically ill patients.

Authors:  Paolo Cotogni; Mauro Pittiruti
Journal:  World J Crit Care Med       Date:  2014-11-04

6.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

Review 7.  Optimal timing for intravascular administration set replacement.

Authors:  Amanda J Ullman; Marie L Cooke; Donna Gillies; Nicole M Marsh; Azlina Daud; Matthew R McGrail; Elizabeth O'Riordan; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2013-09-15

8.  Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.

Authors:  David Palmero; Emilienne Chavan; Markoulina Berger-Gryllaki; Jean-François Tolsa; Ermindo R Di Paolo; André Pannatier; Hugues Henry; Farshid Sadeghipour
Journal:  Eur J Hosp Pharm       Date:  2017-08-02

9.  Current strategies for the prevention and management of central line-associated bloodstream infections.

Authors:  Zhuolin Han; Stephen Y Liang; Jonas Marschall
Journal:  Infect Drug Resist       Date:  2010-11-23       Impact factor: 4.003

10.  Peripheral Intravenous Catheterisation in Obstetric Patients in the Hand or Forearm Vein: A Randomised Trial.

Authors:  Peng Chiong Tan; Anjana Mackeen; Su Yen Khong; Siti Zawiah Omar; M A Noor Azmi
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.